129 related articles for article (PubMed ID: 4064048)
21. [The clinical significance of pseudouridine determination of the urine in children and adolescents].
Graf N; Bach K; Frisch B; Haas HJ; Sitzmann FC
Klin Padiatr; 1989; 201(3):154-62. PubMed ID: 2739340
[TBL] [Abstract][Full Text] [Related]
22. Serum pseudouridine as a biochemical marker in the development of AKR mouse lymphoma.
Russo T; Colonna A; Salvatore F; Cimino F; Bridges S; Gurgo C
Cancer Res; 1984 Jun; 44(6):2567-70. PubMed ID: 6722793
[TBL] [Abstract][Full Text] [Related]
23. [Non-Hodgkin lymphomas. New histological, cytological and prognostic correlations (author's transl)].
Hérait P; Gérard-Marchant R; Amiel JL; Caillaud JM; Tursz T; Droz JP
Nouv Presse Med; 1981 Jun; 10(27):2267-71. PubMed ID: 7022369
[TBL] [Abstract][Full Text] [Related]
24. [Pseudouridine and uric acid excretion in patients with viral hepatitis].
Lifshits RI; Salomatin VV; Efimenko GP
Vopr Med Khim; 1976; 22(5):687-90. PubMed ID: 1014482
[TBL] [Abstract][Full Text] [Related]
25. [Primary extralymphatic non-Hodgkin's lymphomas: the response to treatment and prognostic factors in 73 patients].
Oriol A; Ribera JM; Flores A; Batlle M; las Heras G; Vaquero M; Juncá J; Millá F; Feliu E
Med Clin (Barc); 1995 Mar; 104(8):281-6. PubMed ID: 7700086
[TBL] [Abstract][Full Text] [Related]
26. Pseudouridine and beta-aminoisobutyric acid excretion in urine: diagnostic and prognostic value.
Kvist E; Sjølin KE
Scand J Urol Nephrol; 1990; 24(4):283-5. PubMed ID: 2274752
[TBL] [Abstract][Full Text] [Related]
27. [Malignant non-Hodgkin's lymphoma of the joint. Report of two cases, review of the literature and problems of classification].
Krüger R; Oden J; de Leon F; Dürr W
Unfallchirurg; 1993 Oct; 96(10):556-62. PubMed ID: 8235678
[TBL] [Abstract][Full Text] [Related]
28. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
[TBL] [Abstract][Full Text] [Related]
29. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
30. [Clinical data and therapy of malignant non-Hodgkin's lymphoma of nasal cavity and paranasal sinuses (author's transl)].
Löbe LP; Katenkamp D
Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):334-7. PubMed ID: 6894956
[TBL] [Abstract][Full Text] [Related]
31. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
[TBL] [Abstract][Full Text] [Related]
32. [Non-Hodgkin's lymphoma: clinical symptoms, therapy and prognosis in 37 patients].
Skunca Z; Gverić-Krecak V; Dominis M; Planinc-Peraica A; Jaksić B
Acta Med Croatica; 2003; 57(4):261-7. PubMed ID: 14639859
[TBL] [Abstract][Full Text] [Related]
33. [Combination of cancer markers in the detection and prognosis of digestive system tumors].
de Mello Júnior JP; Giles GR
Arq Gastroenterol; 1986; 23(3):133-44. PubMed ID: 2449153
[TBL] [Abstract][Full Text] [Related]
34. Comparison of urinary neopterin and pseudouridine in patients with malignant proliferative diseases.
Motyl T; Traczyk Z; Holska W; Daniewska-Michalska D; Cieśluk S; Kukulska W; Kałuzny Z; Podgurniak M
Eur J Clin Chem Clin Biochem; 1993 Apr; 31(4):205-9. PubMed ID: 8318566
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of the advantage of determination of urinary pseudouridine for the early detection of a malignant transformation process].
Senden D; Buchet JP; Lauwerys R
J Toxicol Clin Exp; 1990; 10(7-8):473-80. PubMed ID: 2135063
[TBL] [Abstract][Full Text] [Related]
36. [Interrelationship of pseudouridine and transfer RNA metabolic disorders in thermal injury].
Salomatin VV; Efimenko GP; Kamilov FKh; Lifshits RI
Vopr Med Khim; 1977; 23(5):642-6. PubMed ID: 595499
[TBL] [Abstract][Full Text] [Related]
37. [Clinical staging of malignant lymphoma].
Bongartz G; Peters PE
Radiologe; 1987 Aug; 27(8):355-62. PubMed ID: 3310090
[TBL] [Abstract][Full Text] [Related]
38. Urinary hypoxanthine and pseudouridine as indicators of tumor development in mesothelioma-transplanted nude mice.
Buhl L; Dragsholt C; Svendsen P; Hage E; Buhl MR
Cancer Res; 1985 Mar; 45(3):1159-62. PubMed ID: 3838262
[TBL] [Abstract][Full Text] [Related]
39. Detection of elevated amounts of urinary pseudouridine in cancer patients by use of a monoclonal antibody.
Itoh K; Mizugaki M; Ishida N
Clin Chim Acta; 1989 May; 181(3):305-15. PubMed ID: 2758683
[TBL] [Abstract][Full Text] [Related]
40. [Diagnosis of malignant non-Hodgkin lymphoma on the basis of the Kiel-classification].
Fuchs R; Franke A; Jandl H
Z Gesamte Inn Med; 1979 Apr; 34(7):199-201. PubMed ID: 483926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
